Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Placebo-Pr'
Placebo-Pr published presentations and documents on DocSlides.
Placebo (n = 38) Metoprolol
by unita
(. n . = 37). Metoprolol for AR. Primary endpoint,...
Placebo (n = 2,333) Empaglifozin
by SugarPlumFairy
(. n . = 4,687). EMPA-REG OUTCOME. Primary . outco...
Fludrocortisone does not reduce the risk of recurrent syncope at 12 months compared with placebo i
by delcy
syncope. Given the trend towards benefit though, i...
Alpha Omega MACE: 14.0% with EPA-DHA vs. 13.8% with placebo (p = 0.93)
by delcy
MACE: 13.2% with ALA vs. 14.5% with placebo (p = 0...
Neratinib / Placebo treatment
by heartersh
0. 3. 6. 9. 12. 15. 18. 21. 24. Disease-free survi...
ASCEND Randomized placebo-controlled trial of aspirin 100 mg daily in 15,480 patients with diabetes and no baseline cardiovascular
by mitsue-stanley
ASCEND Randomized placebo-controlled trial of as...
Causal diagrams, the placebo effect, and the expectation effect
by ellena-manuel
Eyal Shahar, MD, MPH. Professor. (. c. redit to D...
Anxiolytic Placebo Response in Outbred Mice
by natalia-silvester
Kelsey I. . Landaverde. , Stacey L. . Kirkpatrick...
What Accounts for Placebo Group
by alida-meadow
Improvements and Can They Be Reduced?. John T. Fa...
Does Meditation Really Work or It’s Placebo effect
by ellena-manuel
Simge ALTINKÖK. Outline. Definition of meditati...
The Placebo Effect
by danika-pritchard
. ...
The Placebo Effect
by alexa-scheidler
Homeopathy. In the late 1700’s a German doctor ...
The Placebo Drift Debate in Antidepressant Clinical Trials
by celsa-spraggs
Zach Daniel White. Biology 101h- . Desaix. Why do...
TDF-FTC versus Placebo as HIV PrEP for Transgender Women
by shmuel184
iPrEx. Trial . Substudy. TDF-FTC versus Placebo a...
Comparison of Adherence among Partners’ PrEP Participants on Placebo before and after Release of
by briana-ranney
B. Wamuti. , J. Odoyo, B. Rono, C. Cohen, E. Buku...
Pravastatin in Elderly Individuals at Risk of Vascular Dise
by min-jolicoeur
Presented at Late Breaking Clinical Trials. AHA 2...
Pravastatin in Elderly Individuals at Risk of Vascular Dise
by phoebe-click
Presented at Late Breaking Clinical Trials. AHA 2...
The Use of Vitamin D in Clinical Practice
by olivia-moreira
John J Cannell, MD. Executive Director, Vitamin D...
Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor
by byrne
Overall survival and updated progression-free surv...
New Insights from EXSCEL
by pongre
M. Angelyn Bethel, MD. Associate Professor of Diab...
Update on Treatment of Myasthenia Gravis
by conchita-marotz
KUMC Neurology Grand Rounds. 07/29/2016. Richard...
Placebos and Stereotypes:
by myesha-ticknor
The amazing power of expectations. Past. Expected...
Learning Objectives Summarize the latest evidence on poly ADP ribose polymerase (PARP) inhibitors i
by zen
knowledge. ). Incorporate evidence-based research ...
HIV Prevention England Conference
by felicity
18 February 2020. -. A two-stage randomised phase ...
Supplementing randomized clinical trials with historical data via Bayesian dynamic borrowing:
by genevieve
A framework to engage with regulatory authorities....
Results from a Phase 2 Randomized, Placebo-Controlled, Double Blind Study of the
by ella
Hedgehog Pathway Antagonist IPI-926 . in Patients ...
Impact of Rosuvastatin on Atherosclerotic Progression in People with HIV at Moderate Cardiovascular
by vivian
Janine Trevillyan. , Matthias . Cavassini. , Jan F...
DR.RAMYA S.S ASSISTANT PROFESSOR
by tremblay
DEPT OF HOMOEOPATHIC PHARMACY. PLACEBO. PLACEBO ...
References (1) Epidemiology
by jordyn
1. Queiroz LP, Peres MF, Piovesan EJ et al. . A na...
s afe and effective use of sedatives
by gagnon
and . analgesics in neonates . Erasmus MC Rotterda...
European Medicines Agency 7 Westferry Circus Canary Wharf London E1
by oconnor
ICH Topic E 12 Evaluation of New An ICH PRINCIPL...
CETP inhibition : Where
by rodriguez
are we . now. ?. Prof. John Kastelein. Academic. ...
Phase 2 Trial Evaluating the Effect of Dexpramipexole on Eosinophil Biomarkers and Lung Function in
by thomas
Professor Salman Siddiqui, Clinical Professor of A...
ACE Primary Results Presentation
by jalin
European Association for the Study of Diabetes. Li...
J. Brady Scott, MSc , RRT-ACCS
by pagi
Assistant Professor . Department of Respiratory Ca...
Dr Krishnadas. N C Associate Professor Neurology, MES Medical College
by emma
. DM Neurology (2011-2014) - Government Medical...
Submitter Name: Marta Ceko
by jasmine
PI Name: Tor D. WagerPI email: tor.wager@colorado....
PPAR activation Clinical
by maniakti
evidence. Evolution of clinical evidence supportin...
AMERICAN COLLEGE OF CARDIOLOGY SCIENTIFIC SESSIONS 2019
by yoshiko-marsland
AMERICAN COLLEGE OF CARDIOLOGY SCIENTIFIC SESSION...
Trial Design Evolocumab SC
by danika-pritchard
140 mg Q2W or 420 mg QM. Placebo SC. Q2W or QM. L...
Load More...